Prescription opioid use among disabled medicare beneficiaries: Intensity, trends, and regional variation

Medical Care

Volumn 52, Issue 9, 2014, Pages 852-859

  Morden, Nancy E ^a   Munson, Jeffrey C ^a   Colla, Carrie H ^a   Skinner, Jonathan S ^a   Bynum, Julie P W ^a   Zhou, Weiping ^a   Meara, Ellen ^a,b  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

Author keywords

disabled; Medicare; opioid analgesics; regional variation

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE;

ADULT; ARTICLE; DISABLED PERSON; DRUG OVERDOSE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICARE; MIDDLE AGED; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

ADULT; ANALGESICS, OPIOID; CHRONIC DISEASE; DISABLED PERSONS; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MEDICARE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84906051986     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000000183     Document Type: Article

References (44)

1. Centers for Disease C, Prevention. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2011;60:1487-1492.
2. US Social Security Administration. Annual statistical report on the social security disability insurance program, 2012. 2011. Available at: http://www.socialsecurity.gov/policy/docs/statcomps/di-Asr/2011/index. html. Accessed July 1, 2013.
3. Autor DH, Duggan MG. The growth in the Social Security Disability rolls: a fiscal crisis unfolding. J Econ Perspect. 2006;20:71-96.
4. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943-1953.
5. Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006;31:506-511.
6. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300: 2613-2620.
7. Gomes T, Redelmeier DA, Juurlink DN, et al. Opioid dose and risk of road trauma in Canada: a population-based study. JAMA Intern Med. 2013;173:196-201.
8. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309:657-659.
9. Substance Abuse and Mental Health Services Administration. Substance Abuse and Mental Health Services Administration, Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: U.S. Department of Health and Human Services; 2011.
10. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women-United States, 1999-2010. 2013. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ mm6226a3.htm?s-cid=mm6226a3-w. Accessed July 29, 2013.
11. Meier B, Marsh B. The soaring cost of the opioid economy. NY Times (Print). 2013;2013. http://www.nytimes.com/interactive/2013/06/23/sunday-review/ the-soaring-cost-of-The-opioid-economy.html?emc=eta1&- r=1&. Accessed July 19, 2014.
12. Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18:1166-1175.
13. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363:1981-1985.
14. Research Data Assistance Center. Find a CMS data file. 2014. Available at: http://www.resdac.org/cms-data/search?f%5B0%5D=im-field-privacy- level%3A42. Accessed May 12, 2014.
15. Washington State Agency Medical Directors' Group. Opiod Dose Calculator. 2010; http://agencymeddirectors.wa.gov/mobile.html. Accessed July 4, 2013.
16. Medcalc.com. Narcotic equivalence converter. 2001. Available at: http://www.medcalc.com/narcotics.html. Accessed July 4, 2013.
17. Centers for Disease Control and Prevention. Emergency department visits involving nonmedical use of selected prescription drugs-United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2010;59:705-709.
18. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
19. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
20. Constantijn Panis, Roald Euller, Cynthia Grant, et al. SSA Program Data User's Manual. Santa Monica CA: RAND Corporation; 2000.
21. Centers for Medicare & Medicaid Services. 2011 Rx-HCC Model Software. 2012; http://www.cms.gov/Medicare/Health-Plans/Medicare AdvtgSpecRateStats/ Risk-Adjustors-Items/Risk2006-2011.html?DLPage = 1&DLSort = 0&DLSortDir = descending. Accessed November 4, 2012.
22. Robst J, Levy JM, Ingber MJ. Diagnosis-based risk adjustment for medicare prescription drug plan payments. Health Care Financ Rev. 2007;28:15-30.
23. Wennberg JE, Skinner J, Goodman DC, et al. Tracking the Care of Patients with Chronic Illness: The Dartmouth Atlas of Health Care 2008. Lebanon, NH: The Dartmouth Institute for Health Policy and Clinical Practice; 2008.
24. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315-1321.
25. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152:85-92.
26. Franklin GM, Mai J, Wickizer T, et al. Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002. Am J Ind Med. 2005;48:91-99.
27. United States Bone and Joint Initiative. The Burden of Musculoskeletal Diseases in the United States, Second Edition. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2011.
28. Dembe A, Wickizer T, Sieck C, et al. Opioid use and dosing in the workers' compensation setting. A comparative review and new data from Ohio. Am J Ind Med. 2012;55:313-324.
29. Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain. 2008;24:469-478.
30. Chou R, Ballantyne JC, Fanciullo GJ, et al. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10:147-159.
31. Freynhagen R, Geisslinger G, Schug SA. Opioids for chronic non-cancer pain. BMJ. 2013;346:f2937.
32. Nekovarova T, Yamamotova A, Vales K, et al. Common mechanisms of pain and depression: are antidepressants also analgesics? Front Behav Neurosci. 2014;8:99.
33. Sullivan MD, Edlund MJ, Zhang L, et al. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166:2087-2093.
34. Scherrer JF, Svrakic DM, Freedland KE, et al. Prescription opioid analgesics increase the risk of depression. J Gen Intern Med. 2014;29:491-499.
35. McLellan AT, Turner BJ. Chronic noncancer pain management and opioid overdose: time to change prescribing practices. Ann Intern Med. 2010;152:123-124.
36. Centers for Disease Control and Prevention. CDC grand rounds: prescription drug overdoses-A US epidemic. MMWR Morb Mortal Wkly Rep. 2012;61:10-13.
37. Paulozzi LJ. Opioid analgesic involvement in drug abuse deaths in American metropolitan areas. Am J Public Health. 2006;96:1755-1757.
38. Paulozzi LJ, Annest JL. US data show sharply rising drug-induced death rates. Inj Prev. 2007;13:130-132.
39. Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepide-miol Drug Saf. 2008;17:997-1005.
40. US Food and Drug Administration. Risk evaluation and mitigation strategy (REMS) for extended-release and long-Acting opioids. 2012.
41. Available at: http://www.fda.gov/drugs/drugsafety/informationbydrug class/ucm163647.htm. Accessed March 4, 2014.
42. Centers for Disease Control and Prevention. Prescription drug overdose: state laws, selected state legislative strategies governing prescription drug abuse and diversion in the US. 2012. Available at: http://www.cdc.gov/ HomeandRecreationalSafety/Poisoning/laws/index.html. Accessed March 4, 2014.
43. Office of the Inspector General. OIG report: invalid prescriber identifiers on Medicare Part D drug claims CMS requirements. 2011. Available at: http://www.ncpanet.org/pdf/leg/aug11/medicare/oig- npi-report.pdf. Accessed 2014.
44. Volkow ND, Frieden TR, Hyde PS, et al. Medication-Assisted therapies-tackling the opioid-overdose epidemic. N Engl J Med. 2014;370: 2063-2066.